ACHILLION PHARMACEUTICALS INC (ACHN) has 76 open-market insider trades by 26 insiders since 2007. The most active filer is QVT Associates GP LLC, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RA Capital Management, LLC via Rajeev M. Shah | 10% | — | 9 | $102.9M | 2014-09-26 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | — | 1 | $101.0M | 2017-11-20 |
| Peter Kolchinsky | 10% | — | 4 | $65.2M | 2014-09-23 |
| RA Capital Healthcare Fund LP | — | — | 3 | $60.1M | 2014-09-30 |
| QVT Associates GP LLC | 10% | — | 10 | $44.1M | 2014-06-16 |
| Clarus Ventures II, LLC | 10% | — | 1 | $12.1M | 2010-08-20 |
| Dennis Henner | 10% | — | 1 | $9.9M | 2012-05-31 |
| Nicole Vitullo | Dir | — | 3 | $6.0M | 2020-01-28 |
| QVT Fund V LP | 10% | — | 3 | $5.7M | 2013-08-09 |
| Growth Capital Ltd Investor | 10% | — | 3 | $4.5M | 2009-12-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Scheer | Director | Sell | $132K | 2019-11-13 |
| Joseph Truitt | CEO | Sell | $1.7M | 2019-10-16 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | Sell | $101.0M | 2017-11-20 |
| Jason S. Fisherman | Director | Buy | $40K | 2016-12-22 |
| Mary Kay Fenton | CFO | Buy | $10K | 2016-12-05 |
| Martha E. Manning | EVP & General Counsel | Buy | $10K |
Companies that share insiders with ACHN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2016-12-02 |
| Milind Deshpande | CEO | Buy | $10K | 2016-12-02 |
| Joseph Truitt | Chief Commercial Officer | Buy | $14K | 2016-12-02 |
| David Apelian | Chief Medical Officer | Sell | $105K | 2015-12-30 |
| Mary Kay Fenton | CFO | Sell | $438K | 2015-12-28 |
| Nicole Vitullo | Director | Sell | $5.6M | 2015-11-09 |
| Nicole Vitullo | Director | Sell | $77K | 2015-09-25 |
| Nicole Vitullo | Director | Sell | $284K | 2015-08-14 |
| Mary Kay Fenton | EVP and CFO | Sell | $210K | 2015-01-23 |
| Milind Deshpande | President | Sell | $1.5M | 2015-01-21 |